Recent Quotes (30 days)

You have no recent quotes
chg | %


Results 1 - 14 of about 14 for Genentech Inc.�
Company Exchange Symbol Last price Quote change Market cap
PDL BioPharma Inc NASDAQ PDLI 3.79 -0.18 (-4.66%) 638.43M
PDL BioPharma, Inc., manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various ...
Biogen Inc NASDAQ BIIB 286.86 -6.35 (-2.17%) 65.14B
Biogen Inc., formerly Biogen Idec Inc., is a global biopharmaceutical company. The Company is focused on discovering, developing, manufacturing and ...
Genentech, Inc. Private
... human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair. Genentech is wholly owned by Swiss pharma powerhouse Roche.
Array Biopharma Inc NASDAQ ARRY 3.96 -0.08 (-1.98%) 574.00M
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients ...
Exelixis, Inc. NASDAQ EXEL 5.72 +0.25 (4.57%) 1.24B
Exelixis Inc. is a biopharmaceutical company. The Company is engaged in developing small molecule therapies for the treatment of cancer.
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
PDL BIOPHARMA INC. DL-,01 FRA PDL 3.62 -0.09 (-2.40%)
Xenon Pharmaceuticals Inc NASDAQ XENE 9.24 +0.02 (0.22%) 132.26M
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan ...
BIOGEN INC. DL -,0005 FRA IDP 270.33 -2.74 (-1.00%)
BIOGEN INC. DL -,0005 ETR IDP 270.85 -3.15 (-1.15%)
EXELIXIS INC. DL-,01 FRA EX9 5.39 +0.05 (0.97%)
BIOGEN INC. BMV BIIB 4,757.00 -51.02 (-1.06%)